Depomed Inc (DEPO) - Financial and Strategic SWOT Analysis Review

  • ID: 4308210
  • SWOT Analysis
  • 46 pages
  • GlobalData
  • Depomed Inc
1 of 5

FEATURED COMPANIES

  • Arbor Pharmaceuticals LLC
  • Insys Therapeutics Inc
  • Mallinckrodt Plc
  • Pfizer Inc
  • Sentynl Therapeutics Inc
  • MORE
Depomed Inc (DEPO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description - A detailed description of the company’s operations and business divisions.
- Corporate strategy - Analyst’s summarization of the company’s business strategy.
- SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives’ employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities - A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Depomed Inc (Depomed) is a specialty pharmaceutical company that develops and commercializes drugs indicated for the treatment of pain and other diseases of the central nervous system. Its product portfolio comprise products for treatment of indications including postherpetic neuralgia caused due to viral infection, herpes zoster, or nerve damage; management of mild to moderate acute pain in adults; migraine attacks in adults of 18 years of age or above; and pain in cancer patients of 18 years of age and older. The company sells its products to wholesale distributors and retail pharmacies. Depomed also licenses Acuform, its proprietary gastroretentive drug delivery technology. Depomed is headquartered in Newark, California, the US.

Depomed Inc Key Recent Developments

Apr 25,2017: Depomed Announces Appointment of Sharon D. Larkin as Senior Vice President, Human Resources and Administration
Feb 21,2017: Depomed Reports Fourth Quarter and Full Year 2016 Financial Results
Nov 07,2016: Depomed Reports Third Quarter 2016 Financial Results
Sep 30,2016: Depomed Prevails in NUCYNTA Franchise ANDA Litigation Providing Market Exclusivity Until December 2025
Sep 06,2016: Depomed Announces Presentations at PAINWeek 2016

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Arbor Pharmaceuticals LLC
  • Insys Therapeutics Inc
  • Mallinckrodt Plc
  • Pfizer Inc
  • Sentynl Therapeutics Inc
  • MORE
Section 1 - About the Company
Depomed Inc - Key Facts
Depomed Inc - Key Employees
Depomed Inc - Key Employee Biographies
Depomed Inc - Major Products and Services
Depomed Inc - History
Depomed Inc - Company Statement
Depomed Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

Section 2 - Company Analysis
Depomed Inc - Business Description
Depomed Inc - Corporate Strategy
Depomed Inc - SWOT Analysis
SWOT Analysis - Overview
Depomed Inc - Strengths
Depomed Inc - Weaknesses
Depomed Inc - Opportunities
Depomed Inc - Threats
Depomed Inc - Key Competitors

Section 3 - Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

Section 4 - Company’s Lifesciences Financial Deals and Alliances
Depomed Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Depomed Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
Depomed Inc, Recent Deals Summary

Section 5 - Company’s Recent Developments
Apr 25, 2017: Depomed Announces Appointment of Sharon D. Larkin as Senior Vice President, Human Resources and Administration
Feb 21, 2017: Depomed Reports Fourth Quarter and Full Year 2016 Financial Results
Nov 07, 2016: Depomed Reports Third Quarter 2016 Financial Results
Sep 30, 2016: Depomed Prevails in NUCYNTA Franchise ANDA Litigation Providing Market Exclusivity Until December 2025
Sep 06, 2016: Depomed Announces Presentations at PAINWeek 2016
Aug 03, 2016: Depomed Reports Second Quarter 2016 Financial Results
Jul 18, 2016: Depomed Announces Patent Trial and Appeal Board Denial of Inter Partes Review of NUCYNTA Patent
May 05, 2016: Depomed Reports First Quarter 2016 Financial Results

Section 6 - Appendix
Methodology
Ratio Definitions
About the Publisher
Contact Us
Disclaimer

List of Tables:
Depomed Inc, Key Facts
Depomed Inc, Key Employees
Depomed Inc, Key Employee Biographies
Depomed Inc, Major Products and Services
Depomed Inc, History
Depomed Inc, Subsidiaries
Depomed Inc, Key Competitors
Depomed Inc, Ratios based on current share price
Depomed Inc, Annual Ratios
Depomed Inc, Annual Ratios (Cont...1)
Depomed Inc, Annual Ratios (Cont...2)
Depomed Inc, Interim Ratios
Depomed Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Depomed Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
Depomed Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures:
Depomed Inc, Performance Chart (2012 - 2016)
Depomed Inc, Ratio Charts
Depomed Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Depomed Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Sentynl Therapeutics Inc
  • Pfizer Inc
  • Mallinckrodt Plc
  • Insys Therapeutics Inc
  • Arbor Pharmaceuticals LLC
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll